Safety and cost effectiveness of early discharge following microscopic trans-sphenoidal resection of pituitary lesions
Open Access
- 1 January 2011
- journal article
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 2 (1) , 66
Abstract
Inpatient hospitalization following trans-sphenoidal resection of a pituitary neoplasm has traditionally involved a hospital stay of 2 days or more. It has been the policy of the senior pituitary neurosurgeon (GSA) since February 2008 to allow discharge home on postoperative day (POD) 1 if thirst mechanism is intact and the patient is tolerating oral hydration. The goal of this study was to evaluate the safety and cost-effectiveness of this practice. We reviewed the charts of 30 patients, designated the early discharge group, who consecutively underwent microscopic trans-sphenoidal resection from February 2008 to December 2009. We then reviewed the charts of 30 patients, designated the standard discharge group, who consecutively underwent trans-sphenoidal resection from May 2007 to February 2008 before discharge home on POD1 was considered an appropriate option. Safety and cost-effectiveness of the two patient groups were retrospectively evaluated. Patients in the early discharge group went home, on average, on POD 1.3. Following exclusion of two outliers, the average date of discharge of patients in the standard discharge group was POD 2.2. The policy of early discharge saved an average of $1,949 per patient-approximately 4% the total cost of the procedure. Trends toward decreased costs did not reach statistical significance. While no patient suffered any measurable morbidity as a result of early discharge home, 1 in 3 patients in the early discharge group required unscheduled postoperative re-evaluation-a figure significantly higher than the standard discharge group. At a dedicated pituitary center with the resources to closely monitor outpatient endocrinological and postsurgical issues, early discharge home following trans-sphenoidal surgery is a safe option that is associated with an increase in the number of unscheduled postoperative visits and a trend toward lower costs.Keywords
This publication has 28 references indexed in Scilit:
- Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementationJournal of Neurosurgery, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Analysis of Transnasal Endoscopic versus Transseptal Microscopic Approach for Excision of Pituitary TumorsAmerican Journal of Rhinology, 2008
- National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002Neurosurgical Focus, 2007
- Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgeryJournal of Neurosurgery, 2007
- Hyponatremia after Transsphenoidal Surgery for Hypothalamo-Pituitary TumorsNeuroendocrinology, 2006
- Disorders of water metabolism following transsphenoidal pituitary surgery: A single institution’s experiencePituitary, 2006
- DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomasActa Neurochirurgica, 2005
- Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen testClinical Endocrinology, 2005
- Safety of Minimally Invasive Pituitary Surgery (MIPS) Compared with a Traditional ApproachThe Laryngoscope, 2004